BW1003C87, phenytoin and carbamazepine elevate seizure threshold in the rat amygdala-kindling model of epilepsy

European Journal of Pharmacology

Volumn 339, Issue 1, 1997, Pages 11-15

  Morimoto, Kiyoshi ^a   Sato, Hitoshi ^a   Sato, Keiko ^b   Sato, Soichiro ^c   Norihito Yamada, ^c  

^a KAGAWA UNIVERSITY   (Japan)

^b National Minamiokayama Hospital   (Japan)

^c OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Amygdala kindling; Anticonvulsant effects; BW1003C87; Carbamazopine; Phenytoin; Seizure threshold

Indexed keywords

2,4 DIAMINO 5 (2,3,5 TRICHLOROPHENYL)PYRIMIDINE; CARBAMAZEPINE; LAMOTRIGINE; PHENYTOIN; SODIUM; SODIUM CHANNEL;

AMYGDALOID NUCLEUS; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; EPILEPSY; EPILEPTIC FOCUS; INTRAPERITONEAL DRUG ADMINISTRATION; KINDLING; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SEIZURE; SEIZURE THRESHOLD;

AMYGDALA; ANIMALS; ANTICONVULSANTS; CARBAMAZEPINE; DIAZEPAM; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; EPILEPSY; KINDLING, NEUROLOGIC; MALE; NEUROPROTECTIVE AGENTS; PHENYTOIN; PYRIMIDINES; RATS; RATS, SPRAGUE-DAWLEY; SEIZURES;

EID: 0031578551     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)01347-2     Document Type: Article

References (21)

1. Brodie M.J., Richens A., Yuen A.W.C. Double blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. Lancet. 345:1995;476-479.
2. Cheung H., Kamp D., Harris E. An in vitro investigation of the action of lamotrigine on neuronal voltage-activated sodium channels. Epilepsy Res. 13:1992;107-112.
3. Gaspary H.L., Simon R.P., Graham S.H. BW100C87 and NBQX but not CGS19755 reduce glutamate release and cerebral ischemic necrosis. Eur. J. Pharmacol. 262:1994;197-203.
4. Lang D.G., Wang C.M., Cooper B.P. Lamotrigine, phenytoin and carbamazopine interactions on the sodium current present in N4TG1 mouse neuroblastoma cells. J. Pharmacol. Exp. Ther. 266:1992;829-835.
5. Leach M.J., Marden C.M., Miller A.A. Pharmacological studies on lamotrigine, a novel potential antiepileptic drug. II. Neurochemical studies on the mechanism of action. Epilepsia. 27:1986;490-497.
6. Lekieffre D., Meldrum B.S. The pyrimidine-derivative, BW1003C87, protects CA1 and striatal neurons following transient severe forebrain ischemia in rats. A microdialysis and histological study. Neuroscience. 56:1993;93-99.
7. Löscher W., Rundfeldt C., Honack D. Pharmacological characterization of phenytoin-resistant amygdala-kindled rats, a new model of drug resistant partial epilepsy. Epilepsy Res. 15:1993;207-219.
8. Macdonald R.L., Kelly K.M. Antiepileptic drug mechanisms of action. Epilepsia. 36 (Suppl. 2):1995;2-12.
9. Meldrum B.S., Swan J.H., Leach M.J., Millan M.H., Gwinn R., Kadota K., Graham S.H., Chen J., Simon R.P. Reduction of glutamate release and protection against ischemic brain damage by BW1003C87. Brain Res. 593:1992;1-6.
10. Messenheimer J.A. Lamotrigine. Epilepsia. 36 (Suppl. 2):1995;87-94.
11. Morimoto K., Holmes K.H., Goddard G.V. Kindling-induced changes in EEG recorded during stimulation from the site of stimulation. III. Direct pharmacological manipulations in the kindled amygdala. Exp. Neurol. 97:1987;17-34.
12. Morimoto K., Sato H., Yamamoto Y., Watanabe T., Suwaki H. Antiepileptic effects of tiagabine, a selective GABA uptake inhibitor, in the rat kindling model of temporal lobe epilepsy. Epilepsia. 38:1997;966-978.
13. Namba T., Morimoto K., Sato K., Yamada N., Kuroda S. Antiepileptogenic and anticonvulsant effects of NBQX, a selective AMPA receptor antagonist, in the rat kindling model of epilepsy. Brain Res. 638:1993;36-44.
14. Otsuki K., Sato K., Yamada N., Kuroda S., Morimoto K. Effects of lamotrigine on kindled seizures in rats. Epilepsia. 36 (Suppl. 3):1995;40.
15. Paxinos, G., Watson, C., 1986. The Rat Brain in Stereotaxic Coordinates, 2nd ed. Academic Press, New York.
16. Pellock J.M. The clinical efficacy of lamotrigine as an antiepileptic drug. Neurology. 44 (Suppl. 8):1994;29-35.
17. Racine R.J. Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroenceph. Clin. Neurophysiol. 32:1978;281-294.
18. Rogawski M.A., Porter R.J. Antiepileptic drugs: Pharmacological mechanisms and clinical efficacy with consideration of promising developmental stage compounds. Pharmacol. Rev. 42:1990;223-286.
19. Rundfeldt C., Honack D., Löscher W. Phenytoin potently increases the threshold for focal seizures in amygdala-kindled rats. Neuropharmacology. 29:1990;845-851.
20. Sato M., Racine R.J., McIntyre D.C. Kindling: Basic mechanisms and clinical validity. Electroenceph. Clin. Neurophysiol. 76:1990;459-472.
21. + channels in rat hippocampal neurones. Eur. J. Physiol. 430:1995;437-446.